Antimicrobial peptides and proteins of the horse - Insights into a well-armed organism

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Bruhn, Oliver ^a   Grötzinger, Joachim ^b   Cascorbi, Ingolf ^a   Jung, Sascha ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EUKARYOTA;

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HORSE; HORSE DISEASE; IMMUNOLOGY; METABOLISM; PROTEIN MOTIF; REVIEW; SEQUENCE ALIGNMENT;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; ORGAN SPECIFICITY; SEQUENCE ALIGNMENT;

EID: 84858121159     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-98     Document Type: Review

References (193)

1. On a remarkable bacteriolytic element found in tissues and secretions. Fleming A, Proc R Soc Lond B Biol Sci 1922 93 306 317 10.1098/rspb.1922.0023
2. Lysozyme: an antibacterial body present in great concentration in tears, and its relation to infection of the human eye. Ridley F, Proc R Soc Med 1928 21 1495 1506 19986560
3. APD: the Antimicrobial Peptide Database. Wang Z, Wang G, Nucleic Acids Res 2004 32 590 592 10.1093/nar/gkh025 14681488
4. Plant defense and antimicrobial peptides. Castro MS, Fontes W, Protein Pept Lett 2005 12 13 18 15638798 (Pubitemid 40068356)
5. Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria. Duquesne S, Petit V, Peduzzi J, Rebuffat S, J Mol Microbiol Biotechnol 2007 13 200 209 10.1159/000104748 17827970 (Pubitemid 47378149)
6. Mammalian defensins in the antimicrobial immune response. Selsted ME, Ouellette AJ, Nat Immunol 2005 6 551 557 10.1038/ni1206 15908936 (Pubitemid 41710724)
7. Epithelial antimicrobial peptides in host defense against infection. Bals R, Respir Res 2000 1 141 150 10.1186/rr25 11667978
8. Antimicrobial peptides in health and disease. Zasloff M, N Engl J Med 2002 347 1199 1200 10.1056/NEJMe020106 12374882
9. Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules. Metz-Boutigue MH, Shooshtarizadeh P, Prevost G, Haikel Y, Chich JF, Curr Pharm Des 2010 16 1024 1039 10.2174/ 138161210790963823 20030614
10. Human -defensin 2 promotes intestinal wound healing in vitro. Otte JM, Werner I, Brand S, Chromik AM, Schmitz F, Kleine M, Schmidt WE, J Cell Biochem 2008 104 2286 2297 10.1002/jcb.21787 18449938
11. Peptide antimicrobial agents. Jenssen H, Hamill P, Hancock REW, Clin Microbiol Rev 2006 19 491 511 10.1128/CMR.00056-05 16847082 (Pubitemid 44137212)
12. Antimicrobial peptides in action. Leontiadou H, Mark AE, Marrink SJ, J Am Chem Soc 2006 128 12156 12161 10.1021/ja062927q 16967965 (Pubitemid 44413847)
13. The mode of antifungal action of plant, insect and human defensins. Aerts AM, François IE, Cammue BPA, Thevissen K, Cell Mol Life Sci 2008 65 2069 2079 10.1007/s00018-008-8035-0 18360739
14. -defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI, J Virol 2004 78 5147 5156 10.1128/JVI.78.10.5147-5156.2004 15113897 (Pubitemid 38581467)
15. Antimicrobial peptides and peptide antibiotics. Bals R, Med Klin (Munich) 2000 95 496 502 (in German) 10.1007/PL00002139
16. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Lehrer RI, Ganz T, Ann N Y Acad Sci 1996 797 228 239 10.1111/j.1749-6632.1996.tb52963.x 8993365 (Pubitemid 27055594)
17. Antimicrobial peptides of multicellular organisms. Zasloff M, Nature 2002 415 389 395 10.1038/415389a 11807545 (Pubitemid 34100944)
18. Cationic peptides: effectors in innate immunity and novel antimicrobials. Hancock REW, Lancet Infect Dis 2001 1 156 164 10.1016/S1473-3099(01)00092-5 11871492 (Pubitemid 33586049)
19. The pro region of human neutrophil defensin contains a motif that is essential for normal subcellular sorting. Liu L, Ganz T, Blood 1995 85 1095 1103 7849297
20. Intramolecular inhibition of human defensin HNP-1 by its propiece. Valore EV, Martin E, Harwig SSL, Ganz T, J Clin Invest 1996 97 1624 1629 10.1172/JCI118588 8601627 (Pubitemid 26105473)
21. Activation of Paneth cell -defensins in mouse small intestine. Ayabe T, Satchell DP, Pesendorfer P, Tanabe H, Wilson CL, Hagen SJ, Ouellette AJ, J Biol Chem 2002 277 5219 5228 10.1074/jbc.M109410200 11733520 (Pubitemid 34968566)
22. Paneth cell trypsin is the processing enzyme for human defensin-5. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL, Nat Immunol 2002 3 583 590 10.1038/ni797 12021776 (Pubitemid 34662312)
23. Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome. Amid C, Rehaume LM, Brown KL, Gilbert JGR, Dougan G, Hancock REW, Harrow JL, BMC Genomics 2009 10 606 10.1186/1471-2164-10- 606 20003482
24. Structural organization of the bovine cathelicidin gene family and identification of a novel member. Scocchi M, Wang S, Zanetti M, FEBS Lett 1997 417 311 315 10.1016/S0014-5793(97)01310-0 9409740 (Pubitemid 27511611)
25. NK-lysin of channel catfish: gene triplication, sequence variation, and expression analysis. Wang Q, Wang Y, Xu P, Liu Z, Mol Immunol 2006 43 1676 1686 10.1016/j.molimm.2005.09.023 16271391
26. NF-B- and AP-1-mediated induction of human -defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schröder JM, Stange EF, Infect Immun 2004 72 5750 5758 10.1128/IAI.72.10.5750-5758.2004 15385474 (Pubitemid 39303685)
27. Expression of -defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells. Duits LA, Ravensbergen B, Rademaker M, Hiemstra PS, Nibbering PH, Immunology 2002 106 517 525 10.1046/j.1365-2567.2002.01430.x 12153515 (Pubitemid 34994717)
28. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. Hirsch JG, J Exp Med 1956 103 589 611 10.1084/jem.103.5.589 13319580
29. Isolation and partial characterization of mare milk lysozyme. Jáuregui-Adell J, Cladel G, Ferraz-Pina C, Rech J, Arch Biochem Biophys 1972 151 353 355 10.1016/0003-9861(72)90507-3 5044524
30. The lysozyme sensitivity of Streptococcus equinus. Smith DG, Microbios 1973 8 199 207 4589869
31. Purification of equine neutrophil lysozyme and its antibacterial activity against Gram-positive and Gram-negative bacteria. Pellegrini A, Waiblinger S, von Fellenberg R, Vet Res Commun 1991 15 427 435 1803722
32. eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes. Couto MA, Harwig SSL, Cullor JS, Hughes JP, Lehrer RI, Infect Immun 1992 60 5042 5047 1452336
33. Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Couto MA, Harwig SSL, Cullor JS, Hughes JP, Lehrer RI, Infect Immun 1992 60 3065 3071 1639474
34. Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Couto MA, Harwig SSL, Lehrer RI, Infect Immun 1993 61 2991 2994 8514405 (Pubitemid 23182298)
35. Novel cathelicidins in horse leukocytes. Scocchi M, Bontempo D, Boscolo S, Tomasinsig L, Giulotto E, Zanetti M, FEBS Lett 1999 457 459 464 10.1016/S0014-5793(99)01097-2 10471829 (Pubitemid 29414743)
36. Equine -defensin-1: full-length cDNA sequence and tissue expression. Davis EG, Sang Y, Blecha F, Vet Immunol Immunopathol 2004 99 127 132 10.1016/j.vetimm.2003.12.010 15113660 (Pubitemid 38542982)
37. Molecular cloning and characterization of equine NK-lysin. Davis EG, Sang Y, Rush B, Zhang G, Blecha F, Vet Immunol Immunopathol 2005 105 163 169 10.1016/j.vetimm.2004.12.007 15797485 (Pubitemid 41569217)
38. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM, Nat Immunol 2005 6 57 64 10.1038/ni1142 15568027 (Pubitemid 40136696)
39. Assignment of the equine S100A7 gene (psoriasin 1) to chromosome 5p12p13 by fluorescence in situ hybridization and radiation hybrid mapping. Leeb T, Bruhn O, Philipp U, Kuiper H, Regenhard P, Paul S, Distl O, Chowdhary BP, Kalm E, Looft C, Cytogenet Genome Res 2005 109 533 15909364
40. Sequence analysis of a 212 kb defensin gene cluster on ECA 27q17. Looft C, Paul S, Philipp U, Regenhard P, Kuiper H, Distl O, Chowdhary BP, Leeb T, Gene 2006 376 192 198 10.1016/j.gene.2006.03.006 16723195
41. The repertoire of equine intestinal -defensins. Bruhn O, Paul S, Tetens J, Thaller G, BMC Genomics 2009 10 631 10.1186/1471-2164-10-631 20030839
42. A novel horse -defensin: gene transcription, recombinant expression and characterization of the structure and function. Bruhn O, Regenhard P, Michalek M, Paul S, Gelhaus C, Jung S, Thaller G, Podschun R, Leippe M, Grötzinger J, Kalm E, Biochem J 2007 407 267 276 10.1042/BJ20070747 17620056 (Pubitemid 47556991)
43. Novel cathelicidin-derived antimicrobial peptides from Equus asinus. Lu Z, Wang Y, Zhai L, Che Q, Wang H, Du S, Wang D, Feng F, Liu J, Lai R, Yu H, FEBS J 2010 277 2329 2339 10.1111/j.1742-4658.2010.07648.x 20423460
44. Lysozymes in the animal kingdom. Callewaert L, Michiels CW, J Biosci 2010 35 127 160 10.1007/s12038-010-0015-5 20413917
45. The three-dimensional structure of an enzyme molecule. Phillips DC, Sci Am 1966 215 78 90 5978599
46. The amino acid sequence of equine milk lysozyme. McKenzie HA, Shaw DC, Biochem Int 1985 10 23 31 4039138 (Pubitemid 15164139)
47. The calcium-binding property of equine lysozyme. Nitta K, Tsuge H, Sugai S, Shimazaki K, FEBS Lett 1987 223 405 408 10.1016/0014-5793(87)80328-9 3666156
48. 1H-NMR. Tsuge H, Koseki K, Miyano M, Shimazaki K, Chuman T, Matsumoto T, Noma M, Nitta K, Sugai S, Biochim Biophys Acta 1991 1078 77 84 10.1016/0167-4838(91)90095-H 1646637
49. Lysozyme and -lactalbumin: structure, function, and interrelationships. McKenzie HA, White FH Jr, Adv Protein Chem 1991 41 173 315 2069076
50. Equine lysozyme: The molecular basis of folding, self-assembly and innate amyloid toxicity. Morozova-Roche LA, FEBS Lett 2007 581 2587 2592 10.1016/j.febslet.2007.05.023 17531977 (Pubitemid 46829117)
51. 2+ to bovine -lactalbumin and equine lysozyme. Desmet J, van Dael H, van Cauwelaert F, Nitta K, Sugai S, J Inorg Biochem 1989 37 185 191 10.1016/0162-0134(89)80041-8 2600598 (Pubitemid 20072769)
52. Effect of calcium on the stability of mares' milk lysozyme. Lyster RLJ, J Dairy Res 1992 59 331 338 10.1017/S0022029900030600 1401355
53. Partially folded states of equine lysozyme. Structural characterization and significance for protein folding. Van Dael H, Haezebrouck P, Morozova L, Arico-Muendel C, Dobson CM, Biochemistry 1993 32 11886 11894 10.1021/bi00095a018 8218261 (Pubitemid 23344714)
54. Models of the three-dimensional structures of echidna, horse, and pigeon lysozymes: calcium-binding lysozymes and their relationship with -lactalbumins. Acharya KR, Stuart DI, Phillips DC, McKenzie HA, Teahan CG, J Protein Chem 1994 13 569 584 10.1007/BF01901539 7832986 (Pubitemid 24317599)
55. Crystallographic studies of a calcium binding lysozyme from equine milk at 2.5 resolution. Tsuge H, Ago H, Noma M, Nitta K, Sugai S, Miyano M, J Biochem 1992 111 141 143 1569037
56. 2+-specific site in lysozyme. Permyakov SE, Khokhlova TI, Uversky VN, Permyakov EA, Proteins 2010 78 2609 2624 20602456
57. Myelomonocytic myeloproliferative diseases in a horse. Brumbaugh GW, Stitzel KA, Zinkl JG, Feldman BF, J Am Vet Med Assoc 1982 180 313 316 7056685
58. Biochemical studies on equine infectious anaemia. Palomba E, Martone F, Meduri A, Vaccaro A, Damiani N, Folia Vet Lat 1976 6 275 288 1010502
59. Plasma and synovial fluid lysozyme activity in horses with experimental cartilage defects. Torbeck RL, Prieur DJ, Am J Vet Res 1979 40 1531 1536 525871
60. Plasma lysozyme activity of Polish primitive horses under physiological conditions and in experimental fever. Winiewski E, Kuma K, Zentralbl Veterinarmed A 1987 34 776 781 3124401
61. Inflammatory components in uterine fluid from mares with experimentally induced bacterial endometritis. Pycock JF, Allen WE, Equine Vet J 1990 22 422 425 10.1111/j.2042-3306.1990.tb04309.x 2269266
62. Paneth cell degranulation and lysozyme secretion during acute equine alimentary laminitis. Masty J, Stradley RP, Histochemistry 1991 95 529 533 10.1007/BF00315751 1869451
63. Fine structural and histochemical study of equine Paneth cells. Takehana K, Masty J, Yamaguchi M, Kobayashi A, Yamada O, Kuroda M, Park YS, Iwasa K, Abe M, Anat Histol Embryol 1998 27 125 129 10.1111/j.1439-0264.1998.tb00167.x 9591375 (Pubitemid 128442102)
64. Immunocytochemical localization of lysozyme and -defensin in the apocrine glands of the equine scrotum. Yasui T, Fukui K, Nara T, Habata I, Meyer W, Tsukise A, Arch Dermatol Res 2007 299 393 397 10.1007/s00403-007-0766-5 17639436 (Pubitemid 47383845)
65. Heat stability and reactivation of mare milk lysozyme. Jáuregui-Adell J, J Dairy Sci 1975 58 835 838 10.3168/jds.S0022-0302(75) 84646-7 237946
66. Seasonal changes in the white blood cell system, lyzozyme activity and cortisol level in Arabian brood mares and their foals. Gill J, Kompanowska-Jezierska E, Jakubow K, Kott A, Szumska D, Comp Biochem Physiol A Physiol 1985 81 511 523 10.1016/0300-9629(85)91019-9
67. Lysozyme activity in the milk of sucking mares during lactation. Hatzipanagiotou A, Rieland E, Enbergs H, Dtsch Tierarztl Wochenschr 1998 105 148 152 (in German) 9618986 (Pubitemid 128690166)
68. Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration. Maliauskas M, Zamotin V, Jass J, Noppe W, Dobson CM, Morozova-Roche LA, J Mol Biol 2003 330 879 890 10.1016/S0022-2836(03)00551-5 12850154
69. Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity? Maliauskas M, Ostman J, Darinskas A, Zamotin V, Liutkevicius E, Lundgren E, Morozova-Roche LA, J Biol Chem 2005 280 6269 6275 10.1074/jbc.M407273200 15576361 (Pubitemid 40341172)
70. Protein oligomerization induced by oleic acid at the solid-liquid interface-equine lysozyme cytotoxic complexes. Wilhelm K, Darinskas A, Noppe W, Duchardt E, Mok KH, Vukojev V, Schleucher J, Morozova-Roche LA, FEBS J 2009 276 3975 3989 10.1111/j.1742-4658.2009.07107.x 19594832
71. The influence of vitamin E on immune function and response to vaccination in older horses. Petersson KH, Burr DB, Gámez-Chiarri M, Petersson-Wolfe CS, J Anim Sci 2010 88 2950 2958 10.2527/jas.2008-1724 20495123
72. Aspects of glycoconjugate production and lysozyme- and defensins-expression of the ceruminous glands of the horse (Equus przewalskii f. dom.). Yasui T, Tsukise A, Fukui K, Kuwahara Y, Meyer W, Eur J Morphol 2005 42 127 134 10.1080/09243860500202507 16393749 (Pubitemid 43068037)
73. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Sillard R, Jörnvall H, Mutt V, Olsson B, Wigzell H, Dagerlind A, Boman HG, Gudmundsson GH, EMBO J 1995 14 1615 1625 7737114
74. NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells. Andersson M, Gunne H, Agerberth B, Boman A, Bergman T, Olsson B, Dagerlind Wigzell H, Boman HG, Gudmundsson GH, Vet Immunol Immunopathol 1996 54 123 126 10.1016/S0165-2427(96)05677-2 8988855 (Pubitemid 27035578)
75. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. Andersson M, Curstedt T, Jörnvall H, Johansson J, FEBS Lett 1995 362 328 332 10.1016/0014-5793(95) 00268-E 7729523
76. Characterization of bovine homologues of granulysin and NK-lysin. Endsley JJ, Furrer JL, Endsley MA, McIntosh MA, Maue AC, Waters WR, Lee DR, Estes DM, J Immunol 2004 173 2607 2614 15294977 (Pubitemid 39063120)
77. Molecular cloning and characterization of chicken NK-lysin. Hong YH, Lillehoj HS, Dalloul RA, Min W, Miska KB, Tuo W, Lee SH, Han JY, Lillehoj EP, Vet Immunol Immunopathol 2006 110 339 347 10.1016/j.vetimm.2005.11.002 16387367
78. Characterization of Japanese flounder (Paralichthys olivaceus) NK-lysin, an antimicrobial peptide. Hirono I, Kondo H, Koyama T, Arma NR, Hwang JY, Nozaki R, Midorikawa N, Aoki T, Fish Shellfish Immunol 2007 22 567 575 10.1016/j.fsi.2006.08.003 17046282 (Pubitemid 46176648)
79. A novel member of the NK-lysin protein family is developmentally regulated and secreted by Fasciola hepatica. Reed MB, Strugnell RA, Panaccio M, Spithill TW, Mol Biochem Parasitol 2000 105 297 303 10.1016/S0166-6851(99)00185- 1 10693752 (Pubitemid 30067769)
80. Granulysin: A novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Krensky AM, Biochem Pharmacol 2000 59 317 320 10.1016/S0006-2952(99)00177-X 10644038 (Pubitemid 30015959)
81. Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite. Leippe M, Cell 1995 83 17 18 10.1016/0092-8674(95)90229-5 7553868
82. Increases in cytokine and antimicrobial peptide gene expression in horses by immunomodulation with Propionibacterium acnes. Davis EG, Rush BR, Blecha F, Vet Ther 2003 4 5 11 12756631
83. Immunomodulation in horses. Rush BR, Flaminio MJBF, Vet Clin North Am Equine Pract 2000 16 183 197, viii 10752146
84. Immunologic function in horses after non-specific immunostimulant administration. Flaminio MJ, Rush BR, Shuman W, Vet Immunol Immunopathol 1998 63 303 315 10.1016/S0165-2427(98)00111-1 9656421 (Pubitemid 28446298)
85. Granulins, a novel class of peptide from leukocytes. Bateman A, Belcourt D, Bennett H, Lazure C, Solomon S, Biochem Biophys Res Commun 1990 173 1161 1168 10.1016/S0006-291X(05)80908-8 2268320
86. The WDNM1 gene product is a novel member of the 'four-disulphide core' family of proteins. Dear TN, Kefford RF, Biochem Biophys Res Commun 1991 176 247 254 10.1016/0006-291X(91)90916-U 2018519
87. Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. Dear TN, Ramshaw IA, Kefford RF, Cancer Res 1988 48 5203 5209 3136918
88. WDNM1 is associated with differentiation and apoptosis of mammary epithelial cells. Kho Y, Kim S, Yoon BS, Moon JH, Kwak S, Park G, Woo J, Oh S, Hong K, Kim S, Kim H, You S, Choi Y, Anim Biotechnol 2008 19 89 103 10.1080/10495390801887361 18432400 (Pubitemid 351599566)
89. Isolation and characterization of three protein proteinase isoinhibitors from the granular fraction of horse neutrophilic granulocytes. Pellegrini A, Hägeli G, von Fellenberg R, Biochem Biophys Res Commun 1988 154 1107 1113 10.1016/0006-291X(88)90255-0 3408487
90. Isolation and characterization of two new low-molecular-weight protein proteinase inhibitors from the granule-rich fraction of equine neutrophilic granulocytes. Pellegrini A, Hägeli G, von Fellenberg R, Biochim Biophys Acta 1988 952 309 316 3276354 (Pubitemid 18051024)
91. Equinins in equine neutrophils: quantification in tracheobronchial secretions as an aid in the diagnosis of chronic pulmonary disease. Pellegrini A, Kalkinc M, Hermann M, Grünig B, Winder C, von Fellenberg R, Vet J 1998 155 257 262 10.1016/S1090-0233(05)80022-X 9638072 (Pubitemid 128679240)
92. S100 proteins: structure, functions and pathology. Heizmann CW, Fritz G, Schäfer BW, Front Biosci 2002 7 1356 d1368 10.2741/heizmann 11991838
93. Identification of a group of proteins that are strongly up-regulated in total epidermal keratinocytes from psoriatic skin. Celis JE, Crüger D, Kiil J, Lauridsen JB, Ratz G, Basse B, Celis A, FEBS Lett 1990 262 159 164 10.1016/0014-5793(90)80179-M 2185946 (Pubitemid 20104286)
94. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. Madsen P, Rasmussen HH, Leffers H, Honoré B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, Lauridsen J, Ratz G, Celis A, Vandekerckhove J, Celis J, J Invest Dermatol 1991 97 701 712 10.1111/1523-1747.ep12484041 1940442
95. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Gläser R, J Cancer Res Clin Oncol 2007 133 253 261 10.1007/s00432-006-0164- y 17136347
96. Psoriasin: a novel chemotactic protein. Jinquan T, Vorum H, Grønhøj Larsen C, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honoré B, Celis JE, Thestrup-Pedersen K, J Invest Dermatol 1996 107 5 10 10.1111/1523-1747.ep12294284 8752830
97. Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue. Meyer JE, Harder J, Sipos B, Maune S, Klöppel G, Bartels J, Schröder JM, Glaser R, Mucosal Immunol 2008 1 239 243 10.1038/mi.2008.3 19079183 (Pubitemid 351541309)
98. Psoriasin (S100A7) is a major Escherichia coli-cidal factor of the female genital tract. Mildner M, Stichenwirth M, Abtin A, Eckhart L, Sam C, Gläser R, Schröder JM, Gmeiner R, Mlitz V, Pammer J, Geusau A, Tschachler E, Mucosal Immunol 2010 3 602 609 10.1038/mi.2010.37 20571488
99. The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. Michalek M, Gelhaus C, Hecht O, Podschun R, Schröder JM, Leippe M, Grötzinger J, Dev Comp Immunol 2009 33 740 746 10.1016/j.dci.2008.12.005 19162067
100. Characterization of equine antimicrobial peptides. Bruhn O, Diploma thesis Christian-Albrechts-University, Institute of Animal Breeding 2005
101. The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. Zanetti M, Del Sal G, Storici P, Schneider C, Romeo D, J Biol Chem 1993 268 522 526 8416958 (Pubitemid 23021353)
102. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. Zanetti M, Gennaro R, Romeo D, FEBS Lett 1995 374 1 5 10.1016/0014-5793(95)01050-O 7589491
103. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Ramanathan B, Davis EG, Ross CR, Blecha F, Microbes Infect 2002 4 361 372 10.1016/S1286-4579(02)01549-6 11909747 (Pubitemid 34293642)
104. Cathelicidins, multifunctional peptides of the innate immunity. Zanetti M, J Leukoc Biol 2004 75 39 48 12960280 (Pubitemid 38166778)
105. The role of cathelicidins in the innate host defenses of mammals. Zanetti M, Curr Issues Mol Biol 2005 7 179 196 16053249 (Pubitemid 41051685)
106. Localization and genomic organization of sheep antimicrobial peptide genes. Huttner KM, Lambeth MR, Burkin HR, Burkin DJ, Broad TE, Gene 1998 206 85 91 10.1016/S0378-1119(97)00569-6 9461419 (Pubitemid 28029639)
107. Bactericidal activity of mammalian cathelicidin-derived peptides. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF, Infect Immun 2000 68 2748 2755 10.1128/IAI.68.5.2748-2755.2000 10768969 (Pubitemid 30253851)
108. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. Giacometti A, Cirioni O, Barchiesi F, Caselli F, Scalise G, J Antimicrob Chemother 1999 44 403 406 10.1093/jac/44.3.403 10511411 (Pubitemid 29425695)
109. Mode of action of the antimicrobial peptide indolicidin. Falla TJ, Karunaratne DN, Hancock REW, J Biol Chem 1996 271 19298 19303 10.1074/jbc.271.32.19298 8702613 (Pubitemid 26271598)
110. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity. Shin SY, Kang SW, Lee DG, Eom SH, Song WK, Kim JI, Biochem Biophys Res Commun 2000 275 904 909 10.1006/bbrc.2000.3269 10973820
111. Structural and functional analysis of horse cathelicidin peptides. Skerlavaj B, Scocchi M, Gennaro R, Risso A, Zanetti M, Antimicrob Agents Chemother 2001 45 715 722 10.1128/AAC.45.3.715-722.2001 11181349 (Pubitemid 32182014)
112. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. Dathe M, Wieprecht T, Nikolenko H, Handel L, Maloy WL, MacDonald DL, Beyermann M, Bienert M, FEBS Lett 1997 403 208 212 10.1016/S0014-5793(97)00055-0 9042968 (Pubitemid 27081496)
113. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Bals R, Wang X, Zasloff M, Wilson JM, Proc Natl Acad Sci USA 1998 95 9541 9546 10.1073/pnas.95.16.9541 9689116 (Pubitemid 28506267)
114. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N, Sthle-Bäckdahl M, Infect Immun 1999 67 2561 2566 10225921 (Pubitemid 29200519)
115. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Heilborn JD, Frohm Nilsson M, Chamorro Jimenez CI, Sandstedt B, Borregaard N, Tham E, Sørensen OE, Weber G, Sthle M, Int J Cancer 2005 114 713 719 10.1002/ijc.20795 15609314 (Pubitemid 40344432)
116. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Lehrer RI, Lichtenstein AK, Ganz T, Annu Rev Immunol 1993 11 105 128 10.1146/annurev.iy.11.040193.000541 8476558 (Pubitemid 23115003)
117. Defensins: antimicrobial peptides of innate immunity. Ganz T, Nat Rev Immunol 2003 3 710 720 10.1038/nri1180 12949495 (Pubitemid 41070812)
118. Defensins of vertebrate animals. Lehrer RI, Ganz T, Curr Opin Immunol 2002 14 96 102 10.1016/S0952-7915(01)00303-X 11790538 (Pubitemid 34085112)
119. Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Seebah S, Suresh A, Zhuo S, Choong YH, Chua H, Chuon D, Beuerman R, Verma C, Nucleic Acids Res 2007 35 265 D268 10.1093/nar/gkl866 17090586 (Pubitemid 46056211)
120. Defensins: endogenous antibiotic peptides from human leukocytes. Lehrer RI, Ganz T, Ciba Found Symp 1992 171 276 290; discussion 290-293 1302183
121. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, Mok SC, Am J Pathol 1998 152 1247 1258 9588893 (Pubitemid 28221877)
122. RK-2: a novel rabbit kidney defensin and its implications for renal host defense. Wu ER, Daniel R, Bateman A, Peptides 1998 19 793 799 10.1016/S0196-9781(98)00016-3 9663443 (Pubitemid 28312275)
123. Secretion of microbicidal -defensins by intestinal Paneth cells in response to bacteria. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ, Nat Immunol 2000 1 113 118 10.1038/77783 11248802
124. Identification of novel host defense peptides and the absence of -defensins in the bovine genome. Fjell CD, Jenssen H, Fries P, Aich P, Griebel P, Hilpert K, Hancock REW, Cherkasov A, Proteins 2008 73 420 430 10.1002/prot.22059 18442133
125. Rapid evolution and diversification of mammalian -defensins as revealed by comparative analysis of rodent and primate genes. Patil A, Hughes AL, Zhang G, Physiol Genomics 2004 20 1 11 10.1152/physiolgenomics.00150.2004 15494476
126. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated -defensins. Tang YQ, Yuan J, sapay G, sapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME, Science 1999 286 498 502 10.1126/science.286.5439.498 10521339
127. Evolution of primate -defensins: a serpentine path to a sweet tooth. Nguyen TX, Cole AM, Lehrer RI, Peptides 2003 24 1647 1654 10.1016/j.peptides. 2003.07.023 15019196 (Pubitemid 38198072)
128. Homodimeric -defensins from Rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. Tran D, Tran PA, Tang YQ, Yuan J, Cole T, Selsted ME, J Biol Chem 2002 277 3079 3084 10.1074/jbc.M109117200 11675394 (Pubitemid 34953167)
129. Cryptdins: antimicrobial defensins of the murine small intestine. Eisenhauer PB, Harwig SSL, Lehrer RI, Infect Immun 1992 60 3556 3565 1500163
130. Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of -defensins from rhesus macaque leukocytes. Tang YQ, Yuan J, Miller CJ, Selsted ME, Infect Immun 1999 67 6139 6144 10531277 (Pubitemid 29508147)
131. Antimicrobial properties of the equine -defensin DEFA1 against bacterial horse pathogens. Bruhn O, Cauchard J, Schlusselhuber M, Gelhaus C, Podschun R, Thaller G, Laugier C, Leippe M, Grötzinger J, Vet Immunol Immunopathol 2009 130 102 106 10.1016/j.vetimm.2009.01.005 19211153
132. Antimicrobial activity of phagocyte granule proteins. Ganz T, Selsted ME, Lehrer RI, Semin Respir Infect 1986 1 107 117 3317602
133. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers a-defensin production. Chalifour A, Jeannin P, Gauchat J-F, Blaecke A, Malissard M, N'Guyen T, Thieblemont N, Delneste Y, Blood 2004 104 1778 1783 10.1182/blood-2003-08-2820 15166032 (Pubitemid 39202287)
134. Modulation of human -defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. Tsutsumi-Ishii Y, Nagaoka I, J Immunol 2003 170 4226 4236 12682256 (Pubitemid 36428189)
135. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ, J Biol Chem 1996 271 2935 2940 10.1074/jbc.271.6.2935 8621683 (Pubitemid 26055594)
136. -defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OMZ, Oppenheim JJ, Science 1999 286 525 528 10.1126/science.286.5439.525 10521347
137. Antimicrobial proteins act as "alarmins" in joint immune defense. Yang D, Oppenheim JJ, Arthritis Rheum 2004 50 3401 3403 10.1002/art.20604 15529365 (Pubitemid 39488662)
138. Comparative genomic analysis of a mammalian -defensin gene cluster. Radhakrishnan Y, Fares MA, French FS, Hall SH, Physiol Genomics 2007 30 213 222 10.1152/physiolgenomics.00263.2006 17456736 (Pubitemid 47296182)
139. Strain-specific polymorphisms in Paneth cell -defensins of C57BL/6 mice and evidence of vestigial myeloid -defensin pseudogenes. Shanahan MT, Tanabe H, Ouellette AJ, Infect Immun 2011 79 459 473 10.1128/IAI.00996-10 21041494
140. A genome-wide screen identifies a single -defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins. Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, Zhang G, BMC Genomics 2004 5 56 10.1186/1471-2164-5-56 15310403 (Pubitemid 39546661)
141. The human -defensin-1 and -defensins are encoded by adjacent genes: Two peptide families with differing disulfide topology share a common ancestry. Liu L, Zhao C, Heng HH, Ganz T, Genomics 1997 43 316 320 10.1006/geno.1997.4801 9268634 (Pubitemid 27353707)
142. Evolution of multigene families by gene duplication. A haploid model. Tachida H, Kuboyama T, Genetics 1998 149 2147 2158 9691065 (Pubitemid 28375979)
143. Arthropod defensins illuminate the divergence of scorpion neurotoxins. Froy O, Gurevitz M, J Pept Sci 2004 10 714 718 10.1002/psc.578 15635623 (Pubitemid 40012313)
144. Evidence for myxobacterial origin of eukaryotic defensins. Zhu S, Immunogenetics 2007 59 949 954 10.1007/s00251-007-0259-x 18058146 (Pubitemid 50006381)
145. Defensins of the horse. Bruhn O, PhD thesis Christian-Albrechts- University, Institute of Animal Breeding 2009
146. Structural and functional characterization of the conserved salt bridge in mammalian paneth cell -defensins: solution structures of mouse cryptdin-4 and (E15D)-cryptdin-4. Rosengren KJ, Daly NL, Fornander LM, Jönsson LM, Shirafuji Y, Qu X, Vogel HJ, Ouellette AJ, Craik DJ, J Biol Chem 2006 281 28068 28078 10.1074/jbc.M604992200 16857681 (Pubitemid 44414520)
147. 13 salt bridge conserved in mammalian -defensins? Wu Z, Li X, de Leeuw E, Ericksen B, Lu W, J Biol Chem 2005
148. Reconstruction of the conserved b-bulge in mammalian defensins using D-amino acids. Xie C, Prahl A, Ericksen B, Wu Z, Zeng P, Li X, Lu WY, Lubkowski J, Lu W, J Biol Chem 2005 280 32921 32929 10.1074/jbc.M503084200 15894545 (Pubitemid 41368342)
149. Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Shamova O, Brogden KA, Zhao C, Nguyen T, Kokryakov VN, Lehrer RI, Infect Immun 1999 67 4106 4111 10417180 (Pubitemid 29357034)
150. Copy number polymorphism and expression level variation of the human -defensin genes DEFA1 and DEFA3. Aldred PMR, Hollox EJ, Armour JAL, Hum Mol Genet 2005 14 2045 2052 10.1093/hmg/ddi209 15944200 (Pubitemid 41418040)
151. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Ouellette AJ, Hsieh MM, Nosek MT, Cano-Gauci DF, Huttner KM, Buick RN, Selsted ME, Infect Immun 1994 62 5040 5047 7927786 (Pubitemid 24332813)
152. Paneth cell defensins: endogenous peptide components of intestinal host defense. Ouellette AJ, Selsted ME, FASEB J 1996 10 1280 1289 8836041 (Pubitemid 26307513)
153. Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. Karlsson J, Pütsep K, Chu H, Kays RJ, Bevins CL, Andersson M, BMC Immunol 2008 9 37 10.1186/1471-2172-9-37 18637162
154. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K, FEBS Lett 2000 480 147 150 10.1016/S0014-5793(00) 01920-7 11034317
155. Hepcidin: iron-hormone and anti-microbial peptide. Verga Falzacappa MV, Muckenthaler MU, Gene 2005 364 37 44 16203112 (Pubitemid 41773232)
156. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Park CH, Valore EV, Waring AJ, Ganz T, J Biol Chem 2001 276 7806 7810 10.1074/jbc.M008922200 11113131
157. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. Hunter HN, Fulton DB, Ganz T, Vogel HJ, J Biol Chem 2002 277 37597 37603 10.1074/jbc.M205305200 12138110
158. Cloning, sequencing and expression analysis of the equine hepcidin gene by real-time PCR. Oliveira Filho JP, Badial PR, Cunha PH, Cruz TF, Araujo JP Jr, Divers TJ, Winand NJ, Borges AS, Vet Immunol Immunopathol 2010 135 34 42 10.1016/j.vetimm.2009.10.027 19945753
159. In vitro antibacterial properties of pexiganan, an analog of magainin. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M, Antimicrob Agents Chemother 1999 43 782 788 10103181 (Pubitemid 29165740)
160. Pexiganan-incorporated collagen matrices for infected wound-healing processes in rat. Gopinath D, Kumar MS, Selvaraj D, Jayakumar R, J Biomed Mater Res A 2005 73 320 331 15800884 (Pubitemid 40664298)
161. Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Gottler LM, Ramamoorthy A, Biochim Biophys Acta 2009 1788 1680 1686 10.1016/j.bbamem.2008. 10.009 19010301
162. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Lipsky BA, Holroyd KJ, Zasloff M, Clin Infect Dis 2008 47 1537 1545 10.1086/593185 18990064
163. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial). Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ, PROMPT-CT Trial Investigators, Leuk Lymphoma 2003 44 1165 1172 10.1080/1042819031000079159 12916869 (Pubitemid 36609110)
164. Omiganan pentahydrochloride in the front line of clinical applications of antimicrobial peptides. Melo MN, Dugourd D, Castanho MARB, Recent Pat Antiinfect Drug Discov 2006 1 201 207 18221145
165. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Sader HS, Fedler KA, Rennie RP, Stevens S, Jones RN, Antimicrob Agents Chemother 2004 48 3112 3118 10.1128/AAC.48.8.3112-3118.2004 15273128 (Pubitemid 38989182)
166. Recent patents on antimicrobial peptides. Pathan FK, Venkata DA, Panguluri SK, Recent Pat DNA Gene Seq 2010 4 10 16 10.2174/187221510790410831 20218955
167. Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. Akinbi HT, Epaud R, Bhatt H, Weaver TE, J Immunol 2000 165 5760 5766 11067934
168. Cationic polypeptides are required for antibacterial activity of human airway fluid. Cole AM, Liao HI, Stuchlik O, Tilan J, Pohl J, Ganz T, J Immunol 2002 169 6985 6991 12471133 (Pubitemid 36899286)
169. Role of the lysozyme inhibitor Ivy in growth or survival of Escherichia coli and Pseudomonas aeruginosa bacteria in hen egg white and in human saliva and breast milk. Deckers D, Vanlint D, Callewaert L, Aertsen A, Michiels CW, Appl Environ Microbiol 2008 74 4434 4439 10.1128/AEM.00589-08 18515493 (Pubitemid 352031025)
170. Mouse lysozyme M is important in pulmonary host defense against Klebsiella pneumoniae infection. Markart P, Korfhagen TR, Weaver TE, Akinbi HT, Am J Respir Crit Care Med 2004 169 454 458 14617511 (Pubitemid 38187116)
171. Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. Lee M, Kovacs-Nolan J, Yang C, Archbold T, Fan MZ, Mine Y, J Agric Food Chem 2009 57 2233 2240 10.1021/jf803133b 19231858
172. Lysozyme transgenic goats' milk influences gastrointestinal morphology in young pigs. Brundige DR, Maga EA, Klasing KC, Murray JD, J Nutr 2008 138 921 926 18424602 (Pubitemid 351571593)
173. Consumption of milk from transgenic goats expressing human lysozyme in the mammary gland results in the modulation of intestinal microflora. Maga EA, Walker RL, Anderson GB, Murray JD, Transgenic Res 2006 15 515 519 10.1007/s11248-006-0014-3 16906451 (Pubitemid 44215639)
174. Effect of adjunctive treatment with intravenously administered Propionibacterium acnes on reproductive performance in mares with persistent endometritis. Rohrbach BW, Sheerin PC, Cantrell CK, Matthews PM, Steiner JV, Dodds LE, J Am Vet Med Assoc 2007 231 107 113 10.2460/javma.231.1.107 17605673 (Pubitemid 47016107)
175. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. Andrä J, Monreal D, Martinez de Tejada G, Olak C, Brezesinski G, Gomez SS, Goldmann T, Bartels R, Brandenburg K, Moriyon I, J Biol Chem 2007 282 14719 14728 10.1074/jbc.M608920200 17389605 (Pubitemid 47093359)
176. Molecular basis for endotoxin neutralization by amphipathic peptides derived from the -helical cationic core-region of NK-lysin. Brandenburg K, Garidel P, Fukuoka S, Howe J, Koch MH, Gutsmann T, Andrä J, Biophys Chem 2010 150 80 87 10.1016/j.bpc.2010.01.009 20153101
177. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum. Gelhaus C, Jacobs T, Andrä J, Leippe M, Antimicrob Agents Chemother 2008 52 1713 1720 10.1128/AAC.01342-07 18332165 (Pubitemid 351614664)
178. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Lee PHA, Ohtake T, Zaiou M, Murakami M, Rudisill JA, Lin KH, Gallo RL, Proc Natl Acad Sci USA 2005 102 3750 3755 10.1073/pnas.0500268102 15728389 (Pubitemid 40354683)
179. Control of cutaneous antimicrobial peptides by vitamin D3. Dombrowski Y, Peric M, Koglin S, Ruzicka T, Schauber J, Arch Dermatol Res 2010 302 401 408 10.1007/s00403-010-1045-4 20221619
180. The vitamin D pathway: a new target for control of the skin's immune response? Schauber J, Gallo RL, Exp Dermatol 2008 17 633 639 10.1111/j.1600-0625.2008.00768.x 18573153 (Pubitemid 352044354)
181. Human -defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. Joly S, Maze C, McCray PB Jr, Guthmiller JM, J Clin Microbiol 2004 42 1024 1029 10.1128/JCM.42.3.1024-1029.2004 15004048 (Pubitemid 38332820)
182. The human -defensin-3, an antibacterial peptide with multiple biological functions. Dhople V, Krukemeyer A, Ramamoorthy A, Biochim Biophys Acta 2006 1758 1499 1512 10.1016/j.bbamem.2006.07.007 16978580 (Pubitemid 44444831)
183. Aerosol therapy in the equine species. Duvivier DH, Votion D, Vandenput S, Lekeux P, Vet J 1997 154 189 202 10.1016/S1090-0233(97)80020-2 9414952 (Pubitemid 27497064)
184. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Garcia-Contreras L, Fiegel J, Telko MJ, Elbert K, Hawi A, Thomas M, VerBerkmoes J, Germishuizen WA, Fourie PB, Hickey AJ, Edwards D, Antimicrob Agents Chemother 2007 51 2830 2836 10.1128/AAC.01164-06 17517845 (Pubitemid 47206218)
185. Innate immunity and colonic inflammation. Enhanced expression of epithelial -defensins. Wehkamp J, Schwind B, Herrlinger KR, Baxmann S, Schmidt K, Duchrow M, Wohlschläger C, Feller AC, Stange EF, Fellermann K, Dig Dis Sci 2002 47 1349 1355 10.1023/A:1015334917273 12064812 (Pubitemid 34606640)
186. Reduced Paneth cell -defensins in ileal Crohn's disease. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H Jr, Fellermann K, Ganz T, Stange EF, Bevins CL, Proc Natl Acad Sci USA 2005 102 18129 18134 10.1073/pnas.0505256102 16330776 (Pubitemid 41798513)
187. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M, Dig Liver Dis 2008 40 723 730 10.1016/j.dld.2008.02.011 18394979
188. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. Gesell J, Zasloff M, Opella SJ, J Biomol NMR 1997 9 127 135 10.1023/A:1018698002314 9090128 (Pubitemid 127715704)
189. Three-dimensional structure of RK-1: a novel -defensin peptide. McManus AM, Dawson NF, Wade JD, Carrington LE, Winzor DJ, Craik DJ, Biochemistry 2000 39 15757 15764 10.1021/bi000457l 11123900 (Pubitemid 32038236)
190. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Rozek A, Friedrich CL, Hancock REW, Biochemistry 2000 39 15765 15774 10.1021/bi000714m 11123901 (Pubitemid 32040945)
191. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Mandard N, Sodano P, Labbe H, Bonmatin JM, Bulet P, Hetru C, Ptak M, Vovelle F, Eur J Biochem 1998 256 404 410 10.1046/j.1432-1327.1998. 2560404.x 9760181 (Pubitemid 28404805)
192. Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Trabi M, Schirra HJ, Craik DJ, Biochemistry 2001 40 4211 4221 10.1021/bi002028t 11284676 (Pubitemid 32319567)
193. Protein Calculator v3.3. http://www.scripps.edu/∼cdputnam/protcalc. html